The popularity of GLP-1 agonists to treat obesity has been skyrocketing in recent months, leading to both shortages and price increases
: : 1 - 5 10 , 10 10 : , , - , , DSIP, DSIP 4H2O, WAGGDASGE, EMIDELTIDE, EMideltide, DSIP nonapeptide, SLEEP INDUCING PEPTIDE, DELTA SLEEP INDUCING PEPTIDE, DELTA SLEEP-INDUCING PEPTIDE 4H2O, DSIP/Delta Sleep Inducing Peptide *
However, patients often notice the return of their original conditions, such as increased appetite, weight gain, or higher blood sugar levels
Kumbhani D et al
How Long Do GLP-1 Headaches Typically Last
Whether this finding can be replicated in future studies, and what significance it holds for the broader understanding of GLP-1R agonisms effects on food preference, remains to be determined